JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4876
Purple Innovation
PRPL
$9.33M
| $167K | ﹤0.01% |
1,394
+182
| +15% | +$19.9K |
2018 Q3
17 quarters
|
|
4877
Tarsus Pharmaceuticals
TARS
$3.51B
| $167K | ﹤0.01% |
11,351
+1,309
| +13% | +$21.7K |
2020 Q4
8 quarters
|
|
4878
LendingTree
TREE
$354M
| $167K | ﹤0.01% |
7,833
-3,949
| -34% | -$90K |
2017 Q1
23 quarters
|
|
|
CPE
4879
CALL
DELISTED
Callon Petroleum Company
CPE
| $167K | ﹤0.01% |
4,500
| – | – |
2022 Q1
3 quarters
|
|
|
LVOX
4880
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
| $167K | ﹤0.01% |
56,387
+9,078
| +19% | +$23.9K |
2021 Q3
5 quarters
|
|
|
BOXD
4881
DELISTED
Boxed, Inc.
BOXD
| $167K | ﹤0.01% |
857,207
+376,035
| +78% | +$192K |
2021 Q4
4 quarters
|
|
|
PCSB
4882
DELISTED
PCSB Financial Corporation
PCSB
| $167K | ﹤0.01% |
8,748
+1,516
| +21% | +$29.2K |
2017 Q2
22 quarters
|
|
|
IGR
4883
CBRE Global Real Estate Income Fund
IGR
$586M
| $166K | ﹤0.01% |
9,700
+6,812
| +236% | +$120K |
2022 Q2
2 quarters
|
|
|
BRDG
4884
DELISTED
Bridge Investment Group
BRDG
| $165K | ﹤0.01% |
+13,667
| New | +$197K |
2022 Q4
0 quarters
|
|
|
ETJ
4885
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$548M
| $165K | ﹤0.01% |
+22,051
| New | +$180K |
2022 Q4
0 quarters
|
|
4886
PUT
Labcorp
LH
$25B
| $165K | ﹤0.01% |
+815
| New | +$159K |
2022 Q4
0 quarters
|
|
4887
Global X S&P 500 Covered Call ETF
XYLD
$3.41B
| $165K | ﹤0.01% |
4,203
+3,508
| +505% | +$140K |
2022 Q1
3 quarters
|
|
|
PSTX
4888
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $165K | ﹤0.01% |
31,224
-81,963
| -72% | -$375K |
2020 Q3
9 quarters
|
|
4889
Annexon
ANNX
$798M
| $164K | ﹤0.01% |
31,722
+5,706
| +22% | +$31.4K |
2020 Q3
9 quarters
|
|
4890
Archer Aviation
ACHR
$3.6B
| $163K | ﹤0.01% |
87,415
+7,252
| +9% | +$17.9K |
2022 Q2
2 quarters
|
|
4891
Cato Corp
CATO
$47.6M
| $163K | ﹤0.01% |
17,412
+1,979
| +13% | +$20.2K |
2013 Q2
38 quarters
|
|
4892
Clarivate
CLVT
$940M
| $163K | ﹤0.01% |
19,500
-24,767
| -56% | -$232K |
2019 Q4
12 quarters
|
|
4893
iShares MSCI Italy ETF
EWI
$1.18B
| $163K | ﹤0.01% |
6,047
| – | – |
2020 Q4
8 quarters
|
|
4894
Nature's Sunshine
NATR
$220M
| $163K | ﹤0.01% |
19,675
-12,350
| -39% | -$105K |
2016 Q4
24 quarters
|
|
4895
VictoryShares US Small Cap High Div Volatility Wtd ETF
CSB
$241M
| $162K | ﹤0.01% |
3,139
+3,106
| +9,412% | +$161K |
2022 Q3
1 quarter
|
|
4896
State Street SPDR MSCI USA StrategicFactors ETF
QUS
$1.58B
| $162K | ﹤0.01% |
+1,473
| New | +$162K |
2022 Q4
0 quarters
|
|
|
CMLS
4897
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $162K | ﹤0.01% |
26,092
+11,399
| +78% | +$81.5K |
2019 Q1
15 quarters
|
|
4898
FVCBankcorp
FVCB
$320M
| $161K | ﹤0.01% |
10,493
+2,325
| +28% | +$36.6K |
2021 Q4
4 quarters
|
|
4899
LSI Industries
LYTS
$783M
| $161K | ﹤0.01% |
13,141
-1,016
| -7% | -$10.2K |
2020 Q2
10 quarters
|
|
4900
Vuzix
VUZI
$258M
| $160K | ﹤0.01% |
44,207
-309
| -0.7% | -$1.41K |
2020 Q4
8 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.